4//SEC Filing
Merck & Co., Inc. 4
Accession 0001225208-17-009425
$MRKCIK 0000310158operating
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:42 PM ET
Size
12.3 KB
Accession
0001225208-17-009425
Insider Transaction Report
Form 4
AMBROSE ADELE D
V-P & Chief Com. Officer
Transactions
- Award
Restricted Stock Unit
2017-05-05+2,345→ 2,345 totalFrom: 2020-05-05Exp: 2020-05-05→ Common Stock (2,345 underlying) - Tax Payment
Common Stock
2017-05-09$64.01/sh−960$61,450→ 22,708.329 total - Award
Stock Option (right to buy)
2017-05-05+21,398→ 21,398 totalExercise: $63.97From: 2018-05-05Exp: 2027-05-04→ Common Stock (21,398 underlying) - Exercise/Conversion
Common Stock
2017-05-09+2,576→ 23,668.329 total - Exercise/Conversion
Restricted Stock Unit
2017-05-09$64.01/sh−2,576$164,890→ 0 totalFrom: 2017-05-09Exp: 2017-05-09→ Common Stock (2,576 underlying)
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000310158
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 4:42 PM ET
- Size
- 12.3 KB